These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 1718690)

  • 21. [Myocardial infarction beyond the 48 first hours: treatment with calcium channel antagonists].
    Delahaye F; de Gevigney G; Ovize M; Landrivon G; Rabilloud M; André-Fouët X; Delaye J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1717-24. PubMed ID: 1304145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calcium antagonists in acute myocardial infarction].
    Lotto A; Massari FM; Bertoni T; Ambrosini F; Finzi A; Foresti A; Valentini R; Matta F
    G Ital Cardiol; 1988 Nov; 18(11):974-81. PubMed ID: 3073992
    [No Abstract]   [Full Text] [Related]  

  • 23. Secondary prevention with calcium antagonists after acute myocardial infarction.
    Hansen JF
    Drugs; 1992; 44 Suppl 1():33-43. PubMed ID: 1283582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium antagonists.
    Conti CR; Pepine CJ; Feldman RL; Hill JA
    Cardiology; 1985; 72(5-6):297-321. PubMed ID: 2866840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy.
    Roberts R
    Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differential therapy with calcium antagonists. Hemodynamic studies using nifedipine, verapamil and diltiazem].
    Lehmann HU; Hochrein H
    Dtsch Med Wochenschr; 1985 Apr; 110(17):674-80. PubMed ID: 3987531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium antagonists in the post-myocardial infarction setting.
    Bertolet BD
    Drugs Aging; 1999 Dec; 15(6):461-70. PubMed ID: 10641957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium antagonists and myocardial microperfusion.
    Tillmanns H; Neumann FJ; Parekh N; Waas W; Möller P; Zimmermann R; Steinhausen M; Köbler W
    Drugs; 1991; 42 Suppl 1():1-6. PubMed ID: 1718689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 32. [Calcium antagonists. Properties and current indications].
    Amoroso A; Lanciotti G; Mammarella A
    Recenti Prog Med; 1984 Apr; 75(4):353-60. PubMed ID: 6374795
    [No Abstract]   [Full Text] [Related]  

  • 33. Calcium antagonists in myocardial infarction.
    Zannad F; Sadoul N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S16-9. PubMed ID: 1706009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Calcium antagonists in the secondary prevention of myocardial infarction].
    Lièvre M; Nony P
    Therapie; 1993; 48 Spec No():677-83. PubMed ID: 8091354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonists in the treatment of individuals with ischemic heart disease.
    Winniford MD; Willerson JT; Hillis LD
    Angiology; 1982 Aug; 33(8):522-39. PubMed ID: 6287889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanisms of the protective action of the calcium antagonists corynphar and verapamil in myocardial ischemia and subsequent reperfusion].
    Litvitskiĭ PF
    Farmakol Toksikol; 1982; 45(2):65-70. PubMed ID: 7075755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-angina therapy of coronary heart disease. Mono- or combination treatment].
    Kurz T; Rauch B; Kübler W
    Z Kardiol; 1991 May; 80(5):305-16. PubMed ID: 1678565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.